Hemodialysis is amongst the three therapies of renal replacement used in extracorporeal separation for waste components through the blood in kidney failure cases. Hemodialysis access, even referred to as vascular access, is the way for accessing blood for the hemodialysis, which could be obtained from three varied ways, a graft, a catheter, and a fistula. Hemodialysis access grafts are used for patients having damaged or blocked veins, where fistula can’t be used. However, access graft of hemodialysis doesn’t last long such as fistula that is a major factor expected to restrain growth of the global hemodialysis access graft market in the near future. Rising approvals of products and rising chronic kidney disorders’ incidence is expected to drive growth of the global hemodialysis access graft market over the forecast period. For instance, as per the 2017 factsheet by Centers for Disease Control and Prevention (CDC), 30 Mn people, including 15% adults in the U.S. are estimated to suffer from chronic kidney diseases.
Request for Sample Copy of Research Report at – https://www.coherentmarketinsights.com/insight/request-sample/1840
Global Hemodialysis Access Graft Market Drivers
New product launches from market players is the key factor expected to drive the global hemodialysis access graft market growth over the forecast period. For instance, CryoLife, Inc., in 2013, received mark of CE for HeRO Graft, for patients having blocked veins or failing fistulas leading to the heart. The firm states HeRO graft being the only AV access solution that is fully subcutaneous. Gore & Associates, in 2013, launched the Gore Acuseal vascular graft for the vascular access. Gore Acuseal vascular graft’s key feature is it offers early cannulation that is within a day of post-implantation, due to its design, which is tri-layer with low-bleed elastomeric membrane that is sandwiched among two expanded layers of polytetrafluoroethylene. Several companies are accepting tri-layer design for sustaining in the market of hemodialysis access graft. Thus, this could provide lucrative growth opportunities for new and emerging entrants within the market.
Rising prevalence of final stage renal disease along with other disorders related to kidney is a key factor expected to drive the global hemodialysis access graft market growth. As per the 2017 factsheet by Centers for Disease Control and Prevention (CDC), the amount of people going through end stage renal disease treatments, in 2014, were 118,000 within the U.S., where 662,000 were living upon kidney transplant or chronic dialysis. As per the University of California, in 2013, end stage renal disease is rising by 5% annually in the U.S. As per the Renal Association UK Renal Registry, in 2013, over 57,000 U.K. adults were undergoing kidney failure treatment from which over 42% were getting hemodialysis.
Global Hemodialysis Access Graft Market – Regional Analysis
Based on region, the global hemodialysis access graft market is segmented into North America, Europe, Latin America, Asia Pacific, Africa, and Middle East. North America is expected to hold a dominant position the global hemodialysis access graft market over forecast period. This is due to kidney failure’s high prevalence within the region. For instance, 2015, as per the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), over 661,000 Americans endure from kidney failure, from which 468,000 people are on dialysis.
Asia Pacific is expected to register robust growth, owing large pool of patient having diabetes, increasing the renal failure’s chances. As per the 2017 bulletin by the World Health Organization (WHO), population in South-East Asia is exhibiting massive surge in diabetes’s prevalence. For instance, in 2000, diabetes’s prevalence was 46,903,000, which is projected to be 119,541,000 till 2030. This aspect is expected to drive the global hemodialysis access graft market growth over forecast period.
To get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/1840
Global Hemodialysis Access Graft Market – Competitive Analysis
Major players functioning in the global hemodialysis access graft market include W.L. Gore & Associated, Merit Medical Systems, Inc., Getinge Group, and C. R. Bard.
Companies are focused on acquiring complementary products or business to set foot in the market. For instance, a proprietary disposable medical devices’ marketer and manufacturer, Merit Medical Systems, Inc., in 2016, acquired the HeRO Graft and related assets by Cryolife, Inc., worth US$ 18.5 Mn. Furthermore, Getinge Group acquired Atrium Medical, in 2011, worth US$ 680 Mn. The Atrium’s acquisition is the strategic move from Getinge Group for leveraging technological and scientific developments of both companies and it will also gain access to Atrium Medical’s vascular grafts.
Global Hemodialysis Access Graft Market Taxonomy
- Synthetic Grafts
- Biological Grafts
- Biosynthetic Grafts
By end user:
- Dialysis centers
- Ambulatory Surgical Centers
- Home Care Settings
- North America
- Latin America
- Asia Pacific
- Middle East
Purchase this Premium Research Report – https://www.coherentmarketinsights.com/insight/buy-now/1840
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027